Amylyx Pharmaceuticals, Inc. (AMLX)
31.93
-0.16
(-0.50%)
USD |
NASDAQ |
Sep 11, 14:41
Amylyx Pharmaceuticals Gross Profit (TTM) : -0.369M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.369M |
| March 31, 2026 | -0.467M |
| December 31, 2025 | -0.525M |
| September 30, 2025 | -1.242M |
| June 30, 2025 | -1.736M |
| March 31, 2025 | -10.24M |
| December 31, 2024 | -38.17M |
| September 30, 2024 | 61.45M |
| June 30, 2024 | 159.23M |
| March 31, 2024 | 260.24M |
| December 31, 2023 | 354.26M |
| September 30, 2023 | 274.35M |
| Date | Value |
|---|---|
| June 30, 2023 | 177.19M |
| March 31, 2023 | 84.73M |
| December 31, 2022 | 18.75M |
| September 30, 2022 | -0.154M |
| June 30, 2022 | 0.113M |
| March 31, 2022 | 0.208M |
| December 31, 2021 | 0.233M |
| September 30, 2021 | 0.255M |
| June 30, 2021 | -0.02M |
| March 31, 2021 | -0.01M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Pfizer Inc. | 41.30B |
| Eli Lilly & Co. | 66.44B |
| Merck & Co., Inc. | 48.01B |
| EyePoint, Inc. | -0.51M |
| Bristol Myers Squibb Co. | 32.78B |